dsi.comHome - dsi - dsi.com
dsi.com Profile
dsi.com
Sub Domains:careers.dsi.com
Title:Home - dsi - dsi.com
Description：Daiichi Sankyo Global Website
Keywords：Daiichi Sankyo,DAIICHI SANKYO,Daiichi Sankyo COMPANY LIMITED,Daiichi Sankyo CO LTD...
Discover dsi.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
dsi.com Information
| Website / Domain: | dsi.com |
| HomePage size: | 136.502 KB |
| Page Load Time: | 0.661271 Seconds |
| Website IP Address: | 52.168.54.37 |
| Isp Server: | E.I. du Pont de Nemours and Co. Inc. |
dsi.com Ip Information
| Ip Country: | United States |
| City Name: | Wilmington |
| Latitude: | 39.749801635742 |
| Longitude: | -75.554298400879 |
dsi.com Keywords accounting
| Keyword | Count |
|---|---|
| Daiichi Sankyo | 56 |
| DAIICHI SANKYO | 56 |
| Daiichi Sankyo COMPANY LIMITED | 0 |
| Daiichi Sankyo CO LTD | 0 |
dsi.com Httpheader
| Cache-Control: max-age=0 |
| Keep-Alive: timeout=15, max=99 |
| Transfer-Encoding: chunked |
| Content-Type: text/html;charset=UTF-8 |
| Content-Encoding: gzip |
| Expires: Sun, 04 Oct 2020 11:08:43 GMT |
| Server: Apache |
| Set-Cookie: JSESSIONID=B3E665AFF4252FF244A5FE11C5B0F2F5.MSCAPPPRD08-emktstk7prod; Path=/; Secure; HttpOnly, COOKIE_SUPPORT=true; Expires=Mon, 04-Oct-2021 11:08:43 GMT; Path=/; Secure; HttpOnly, GUEST_LANGUAGE_ID=en_US; Domain=.dsi.com; Expires=Mon, 04-Oct-2021 11:08:43 GMT; Path=/; Secure; HttpOnly, ApplicationGatewayAffinity=571dd80371bd4b9608b9329815aaf461d67a7e2d214fe316729667a643995732;Path=/;Domain=dsi.com, ApplicationGatewayAffinityCORS=571dd80371bd4b9608b9329815aaf461d67a7e2d214fe316729667a643995732;Path=/;Domain=dsi.com;SameSite=None;Secure |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1 |
| Liferay-Portal: Liferay DXP Digital Enterprise 7.0.10 GA1 (Wilberforce / Build 7010 / June 15, 2016) |
| Date: Sun, 04 Oct 2020 11:08:43 GMT |
dsi.com Meta Info
| charset="utf-8"/ |
| content="Daiichi Sankyo Global Website" name="description" |
| content="Daiichi Sankyo,DAIICHI SANKYO,Daiichi Sankyo COMPANY LIMITED,Daiichi Sankyo CO LTD" name="keywords"/ |
| content="user-scalable=no, width=device-width, initial-scale=1.0" name="viewport"/ |
| content="IE=edge" http-equiv="x-ua-compatible" |
| content="text/html; charset=utf-8" http-equiv="content-type"/ |
52.168.54.37 Domains
| Domain | WebSite Title |
|---|
dsi.com Similar Website
| Domain | WebSite Title |
|---|---|
| Home - dsi - dsi.com | |
| DSI Career Site | |
| DSI - Flag Design Studio | |
| Drug and Alcohol Testing | DSI Medical | |
| DSI Portal | Online Stpaul.gov | |
| DSI Consortium airs version 10 specs for DSI3 standard | |
| NDS.SceneBeta.com | Tu comunidad scene de Homebrew Nintendo DS y DSi | |
| DSI – Document Systems, Inc. | Innovative Solutions for IBM System z Data and Applications | |
| DSI Group | DEFENSE STRATEGIES INSTITUTE | Advancing The Mission. Supporting The Force. | |
| DSI Management - A Health Management Company | |
| Home Design Ideas, Home Interior Design, Modern Home Decor, Model Home Furniture at Home Design | |
| Texas Home Inspector | Home Inspection in Spring, Houston, Katy, TX | Sweet Home Inspectors | |
| Home - Liberty Home ContractorsLiberty Home Contractors | When disaster strikes call the experts! | |
| Bob Vila - Home Improvement Home Repair And Home Renovation | |
| Bob Vila - Home Improvement, Home Repair And Home Renovation |
dsi.com Traffic Sources Chart
dsi.com Alexa Rank History Chart
dsi.com Html To Plain Text
Navigation Skip to Content Location Finder | Careers | Healthcare Professionals Toggle navigation Daiichi Sankyo, Inc. About Us Who We Are Values and Mission Company Culture Global Business Strategy and Midterm Plan History Contact Information Partnerships Business Development Alliances At-A-Glance Company Profile Corporate Management Information Company Governance and Global Structure Responsibility Compliance Standards Of Business Conduct Standards of Business Conduct & Ethics for Third Parties Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy California Compliance Declaration California Supply Chains Act Daiichi Sankyo Group Global Business Partner Code of Conduct Transparency and Disclosure Post-marketing Commitments CME and Charitable Contributions Disclosure Working with Healthcare Professionals Vermont Pharmaceutical Marketer Price Disclosure Clinical Study Data Requests Corporate Giving and Support Daiichi Sankyo Requirements Charitable Contributions Sponsorships FAQs Continuing Medical Education (CME) Grants Overview Therapeutic Areas Process FAQs Non-CME Grants Overview Therapeutic Areas Process Patient Assistance Program Supplier Diversity Supplier Registration FAQs Research & Development Pipeline Worldwide R&D Operations Oncology Investigator-Initiated Studies Clinical Study Data Requests Expanded Access to Investigational Products Products Products Safety Data Sheets Media Media Contacts Press Releases Publications Photo Library Locations People Products Theme Search About Us Who We Are Who We Are Values and Mission Company Culture Global Business Strategy and Midterm Plan History Contact Information Partnerships Partnerships Business Development Alliances At-A-Glance Company Profile Company Profile Corporate Management Information Company Governance and Global Structure Responsibility Compliance Compliance Standards Of Business Conduct Standards of Business Conduct & Ethics for Third Parties Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy California Compliance Declaration California Supply Chains Act Daiichi Sankyo Group Global Business Partner Code of Conduct Transparency and Disclosure Transparency and Disclosure Post-marketing Commitments CME and Charitable Contributions Disclosure Working with Healthcare Professionals Vermont Pharmaceutical Marketer Price Disclosure Clinical Study Data Requests Corporate Giving and Support Corporate Giving and Support Daiichi Sankyo Requirements Charitable Contributions Sponsorships FAQs Continuing Medical Education (CME) Grants Continuing Medical Education (CME) Grants Overview Therapeutic Areas Process FAQs Non-CME Grants Non-CME Grants Overview Therapeutic Areas Process Patient Assistance Program Supplier Diversity Supplier Diversity Supplier Registration FAQs Research & Development Pipeline Worldwide R&D Operations Oncology Investigator-Initiated Studies Clinical Study Data Requests Expanded Access to Investigational Products Products Products Safety Data Sheets Media Media Contacts Press Releases Publications Photo Library Photo Library Locations People Products Careers Healthcare Professionals Daiichi Sankyo Worldwide Headquarters Daiichi Sankyo Co. Ltd 3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo 103-8426 Japan Asia Japan · Daiichi Sankyo Co., Ltd. · Daiichi Sankyo ESPHA · Daiichi Sankyo Healthcare · Daiichi Sankyo Propharma · Daiichi Sankyo Chemical Pharma · Daiichi Sankyo RD Novare · Daiichi Sankyo Business Associe · Daiichi Sankyo Happiness · Kitasato Daiichi Sankyo Vaccine China · Daiichi Sankyo Pharmaceutical (Beijing) · Daiichi Sankyo Pharmaceutical (Shanghai) Hong Kong Korea Taiwan Thailand Americas Brazil USA · Daiichi Sankyo, Inc. · American Regent, Inc. · Plexxikon Europe Daiichi Sankyo Europe GmbH Austria Belgium France · Daiichi Sankyo Altkirch Sarl Germany Ireland Italy Portugal Spain Switzerland The Netherlands Turkey United Kingdom Home - dsi Breadcrumb Breadcrumbs -- Home Page Carousal Featured News Featured News Date Title Fri Sep 25 00:00:00 GMT-04:00 2020 ENHERTU® Approved in Japan for the Treatment of Patients with HER2 Positive Metastatic Gastric Cancer Fri Sep 18 00:00:00 GMT-04:00 2020 Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data for Patritumab Deruxtecan in Patients with EGFR-Mutated NSCLC at ESMO 2020 Mon Sep 14 00:00:00 GMT-04:00 2020 Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients with HER3 Expressing Advanced Colorectal Cancer Wed Sep 09 00:00:00 GMT-04:00 2020 Late-Breaking Data for Daiichi Sankyo’s HER3 Directed ADC Patritumab Deruxtecan in EGFR Mutated NSCLC to be Presented at 2020 ESMO Annual Meeting Learn More-HP Updated Learn More Transforming Treatment Together for HER2 Targetable Cancers Antoine Yver, EVP & Global Head, Oncology R&D, Daiichi Sankyo and José Baselga, EVP, R&D Oncology, AstraZeneca discuss the power of collaboration. read more ... COVID-19 Statement Daiichi Sankyo, Inc. has taken measures to contribute to the overall effort to limit the spread of the virus that causes COVID-19. read more ... About Us Who We Are Values and Mission Company Culture Global Business Strategy and Midterm Plan History Contact Information Partnerships Business Development Alliances At-A-Glance Company Profile Corporate Management Information Company Governance and Global Structure Responsibility Compliance Standards Of Business Conduct Standards of Business Conduct & Ethics for Third Parties Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy California Compliance Declaration California Supply Chains Act Daiichi Sankyo Group Global Business Partner Code of Conduct Transparency and Disclosure Post-marketing Commitments CME and Charitable Contributions Disclosure Working with Healthcare Professionals Vermont Pharmaceutical Marketer Price Disclosure Clinical Study Data Requests Corporate Giving and Support Daiichi Sankyo Requirements Charitable Contributions Sponsorships FAQs Continuing Medical Education (CME) Grants Overview Therapeutic Areas Process FAQs Non-CME Grants Overview Therapeutic Areas Process Patient Assistance Program Supplier Diversity Supplier Registration FAQs Research & Development Pipeline Worldwide R&D Operations Oncology Investigator-Initiated Studies Clinical Study Data Requests Expanded Access to Investigational Products Products Products Safety Data Sheets Media Media Contacts Press Releases Publications Photo Library Locations People Products LinkedIn © 2020 Daiichi Sankyo, Inc. All Rights Reserved. Terms and Conditions | Contact Us | Site Map Daiichi Sankyo Worldwide -- -- Headquarters Daiichi Sankyo Co., Ltd 3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo 103-8426 Japan Website in Japanese Asia Japan · Daiichi Sankyo Co., Ltd. · Daiichi Sankyo ESPHA · Daiichi Sankyo Healthcare · Daiichi Sankyo Propharma · Daiichi Sankyo Chemical Pharma · Asubio Pharma -- · Daiichi Sankyo RD Novare · Daiichi Sankyo Business Associe · Daiichi Sankyo Happiness · Kitasato Daiichi Sankyo Vaccine China · Daiichi Sankyo Pharmaceutical (Beijing) · Daiichi Sankyo Pharmaceutical (Shanghai) Hong Kong · Daiichi Sankyo India Pharma Private -- Korea Taiwan Thailand Americas Brazil Mexico (no website) -- USA · Daiichi Sankyo, Inc. · American Regent, Inc. · Plexxikon Venezuela -- Europe Daiichi Sankyo Europe GmbH Austria Belgium France · Daiichi Sankyo Altkirch Sarl Germany · U3 Pharma -- Ireland Italy Portugal Spain Switzerland The Netherlands Turkey United Kingdom · Daiichi Sankyo Development -- Daiichi Sankyo, Inc. http://www.daiichisankyo-us.com American Regent, Inc. https://www.americanregent.com/ Plexxikon Inc. http://www.plexxikon.com Daiichi Sankyo France SAS http://www.daiichi-sankyo.fr Daiichi Sankyo Altkirch Sarl Daiichi Sankyo Europe GmbH http://www.daiichi-sankyo.eu Daiichi Sankyo Deutschland GmbH http://www.daiichi-sankyo.de U3 Pharma GmbH http://www.u3pharma.com -- Daiichi Sankyo Italia S.p.A....
dsi.com Whois
"domain_name": "DSI.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2020-01-21 14:31:51",
"2020-01-21 14:32:03"
],
"creation_date": "1989-04-26 04:00:00",
"expiration_date": "2023-04-27 04:00:00",
"name_servers": [
"NS79.WORLDNIC.COM",
"NS80.WORLDNIC.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"xp6nb7t344u@networksolutionsprivateregistration.com"
],
"dnssec": "unsigned",
"name": "PERFECT PRIVACY, LLC",
"org": null,
"address": "5335 Gate Parkway care of Network Solutions PO Box 459",
"city": "Jacksonville",
"state": "FL",
"zipcode": "32256",
"country": "US"